Inactive Instrument

Other languages InNexus Biotechnology, Inc. Other OTC

Equities

InNexus Biotechnology, Inc. cancelled the transaction announced on May 30, 2013.	13-05-30
INNEXUS BIOTECHNOL : InNexus Biotechnology Announces a Loan Facility of up to USD$2.5 Million	09-03-25
INNEXUS BIOTECHNOL : InNexus Biotechnology Announces New Patents Protecting Novel Cell Penetrating DXL(TM) Antibodies	09-03-06
INNEXUS BIOTECHNOL : InNexus Completes Previously Announced Private Placement	09-01-27
INNEXUS BIOTECHNOL : InNexus Biotechnology CEO Named Business Leader of the Year	08-11-17
INNEXUS BIOTECHNOL : InNexus Biotechnology Receives Patent Grants in Europe	08-10-30
INNEXUS BIOTECHNOL : InNexus Biotechnology CEO to Present at the 7th Annual BIO Investor Forum	08-10-28
INNEXUS BIOTECHNOL : InNexus Biotechnology CEO to Present at BioContactQuebec 2008	08-09-29
INNEXUS BIOTECHNOL : St. Joseph's Hospital and InNexus Biotechnology Enter Collaborative Partnership	08-09-19
INNEXUS BIOTECHNOL : InNexus Biotechnology Strengthens Patent Team With New Leadership	08-09-09
INNEXUS BIOTECHNOL : InNexus Biotechnology CEO to Present at The Wall Street Analyst Forum in NYC	08-09-08
INNEXUS BIOTECHNOL : InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625	08-08-07
INNEXUS BIOTECHNOL : InNexus Biotechnology Announces Third Antibody and Expands Pipeline of Anticancer Compounds	08-08-06
INNEXUS BIOTECHNOL : InNexus Biotechnology CEO and Chief Scientific Officer to Present at IBC's Annual World Congress Conference in Boston on Aug 6th	08-07-31

No results for this search